发布求助
文献互助 智能选刊 最新文献

Immuno-oncology technology最新文献

筛选
英文 中文
91P Identification of T cell receptors from tumour-infiltrating lymphocytes cross-reactive to multiple patient-derived metastatic melanoma cell lines using CRISPR-cas9 mediated TCR replacement 使用CRISPR-cas9介导的TCR替代鉴定肿瘤浸润淋巴细胞对多种患者源性转移性黑色素瘤细胞系交叉反应的T细胞受体
Immuno-oncology technology Pub Date : 2025-12-01 Epub Date: 2025-12-26 DOI: 10.1016/j.iotech.2025.101176
M.D.D. Crowther , M.C.W. Westergaard , L. Schuster , K.H. Johansen , S.A. Tvingsholm , S. Reker Hadrup , I.M. Svane , Ö. Met
{"title":"91P Identification of T cell receptors from tumour-infiltrating lymphocytes cross-reactive to multiple patient-derived metastatic melanoma cell lines using CRISPR-cas9 mediated TCR replacement","authors":"M.D.D. Crowther , M.C.W. Westergaard , L. Schuster , K.H. Johansen , S.A. Tvingsholm , S. Reker Hadrup , I.M. Svane , Ö. Met","doi":"10.1016/j.iotech.2025.101176","DOIUrl":"10.1016/j.iotech.2025.101176","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"28 ","pages":"Article 101176"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145836358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
6P Natural IgM and dyslipidemia enhance the efficacy of tumor necrosis factor and interleukin-2 encoding oncolytic adenovirus in solid tumors 6P天然IgM和血脂异常可增强肿瘤坏死因子和编码溶瘤腺病毒的白介素-2在实体瘤中的作用
Immuno-oncology technology Pub Date : 2025-12-01 Epub Date: 2025-12-26 DOI: 10.1016/j.iotech.2025.101091
J.H.A. Clubb , S.A. Pakola , S. Joenväärä , T. Kudling , T. Tohmola , L. Haybout , V. Arias Illana , E. Jirovec , M. van der Heijden , D.C.A. Quixabeira , T.V. Alanko , K. Jalkanen , M.J. Chisamore , C. Kistler , S. Sorsa , V. Cervera-Carrascon , R. Renkonen , A. Hemminki
{"title":"6P Natural IgM and dyslipidemia enhance the efficacy of tumor necrosis factor and interleukin-2 encoding oncolytic adenovirus in solid tumors","authors":"J.H.A. Clubb , S.A. Pakola , S. Joenväärä , T. Kudling , T. Tohmola , L. Haybout , V. Arias Illana , E. Jirovec , M. van der Heijden , D.C.A. Quixabeira , T.V. Alanko , K. Jalkanen , M.J. Chisamore , C. Kistler , S. Sorsa , V. Cervera-Carrascon , R. Renkonen , A. Hemminki","doi":"10.1016/j.iotech.2025.101091","DOIUrl":"10.1016/j.iotech.2025.101091","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"28 ","pages":"Article 101091"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145836424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
67eP A two-gene signature based on HOXA5 and CEACAM16 predicts survival in IDH-Mutant glioma 基于HOXA5和CEACAM16的双基因标记预测idh突变胶质瘤的生存
Immuno-oncology technology Pub Date : 2025-12-01 Epub Date: 2025-12-26 DOI: 10.1016/j.iotech.2025.101150
M.A. Al-Asadi , H. Khudhur , M.K. Hashki , M.B. Ghanameh , E. Noch
{"title":"67eP A two-gene signature based on HOXA5 and CEACAM16 predicts survival in IDH-Mutant glioma","authors":"M.A. Al-Asadi , H. Khudhur , M.K. Hashki , M.B. Ghanameh , E. Noch","doi":"10.1016/j.iotech.2025.101150","DOIUrl":"10.1016/j.iotech.2025.101150","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"28 ","pages":"Article 101150"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145836525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
76eTiP Prospective evaluation of HERV-K expression and antibody responses in ICI therapy: A biomarker study in NSCLC and HNSCC 在ICI治疗中HERV-K表达和抗体反应的前瞻性评估：一项NSCLC和HNSCC的生物标志物研究
Immuno-oncology technology Pub Date : 2025-12-01 Epub Date: 2025-12-26 DOI: 10.1016/j.iotech.2025.101159
M.D. Müller , J. Friborg , M. Pohl , P.J. Holst , T.B.B. Gaziel
{"title":"76eTiP Prospective evaluation of HERV-K expression and antibody responses in ICI therapy: A biomarker study in NSCLC and HNSCC","authors":"M.D. Müller , J. Friborg , M. Pohl , P.J. Holst , T.B.B. Gaziel","doi":"10.1016/j.iotech.2025.101159","DOIUrl":"10.1016/j.iotech.2025.101159","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"28 ","pages":"Article 101159"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145836484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
12P Stromal CD73 expression in early-stage high-risk luminal B-like breast cancer: An exploratory analysis from the randomized Neo-CheckRay trial 12P基质CD73在早期高危腔内b样乳腺癌中的表达：来自Neo-CheckRay随机试验的探索性分析
Immuno-oncology technology Pub Date : 2025-12-01 Epub Date: 2025-12-26 DOI: 10.1016/j.iotech.2025.101097
Z. Denis , A. De Caluwe , E. Romano , J. Stagg , T. Yin , J. Dhont , F. Lifrange , M. Carausu , C. Sotiriou , L. Buisseret , X. Catteau
{"title":"12P Stromal CD73 expression in early-stage high-risk luminal B-like breast cancer: An exploratory analysis from the randomized Neo-CheckRay trial","authors":"Z. Denis , A. De Caluwe , E. Romano , J. Stagg , T. Yin , J. Dhont , F. Lifrange , M. Carausu , C. Sotiriou , L. Buisseret , X. Catteau","doi":"10.1016/j.iotech.2025.101097","DOIUrl":"10.1016/j.iotech.2025.101097","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"28 ","pages":"Article 101097"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145836653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
35P Integrative transcriptomic profiling of tumor antigens and immune genes in ovarian cancer for rational ADC and CPI combinations 卵巢癌肿瘤抗原和免疫基因的35P整合转录组学分析用于合理的ADC和CPI组合
Immuno-oncology technology Pub Date : 2025-12-01 Epub Date: 2025-12-26 DOI: 10.1016/j.iotech.2025.101118
B.G. Diez, M. García Gómez, M. Amann Arévalo, I. Moreno, C. Gomez Raposo, P. Pérez Segura, J. Bartolomé Arcilla
{"title":"35P Integrative transcriptomic profiling of tumor antigens and immune genes in ovarian cancer for rational ADC and CPI combinations","authors":"B.G. Diez, M. García Gómez, M. Amann Arévalo, I. Moreno, C. Gomez Raposo, P. Pérez Segura, J. Bartolomé Arcilla","doi":"10.1016/j.iotech.2025.101118","DOIUrl":"10.1016/j.iotech.2025.101118","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"28 ","pages":"Article 101118"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145836563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
61P Mapping immune evasion in breast cancer: Subtype-specific signatures that predict survival and ICI benefit 61P在乳腺癌中映射免疫逃避：预测生存和ICI获益的亚型特异性特征
Immuno-oncology technology Pub Date : 2025-12-01 Epub Date: 2025-12-26 DOI: 10.1016/j.iotech.2025.101144
O. Menyhart, B. Gyorffy
{"title":"61P Mapping immune evasion in breast cancer: Subtype-specific signatures that predict survival and ICI benefit","authors":"O. Menyhart, B. Gyorffy","doi":"10.1016/j.iotech.2025.101144","DOIUrl":"10.1016/j.iotech.2025.101144","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"28 ","pages":"Article 101144"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145836610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
52P Sex-specific biomarkers for prediction of immune checkpoint inhibitor efficacy for advanced melanoma using routine blood tests 52P性别特异性生物标志物用于预测免疫检查点抑制剂对晚期黑色素瘤的疗效，使用常规血液检查
Immuno-oncology technology Pub Date : 2025-12-01 Epub Date: 2025-12-26 DOI: 10.1016/j.iotech.2025.101135
C. Liu , S. Wickström , H. Helgadottir , S. Egyhazi Brage
{"title":"52P Sex-specific biomarkers for prediction of immune checkpoint inhibitor efficacy for advanced melanoma using routine blood tests","authors":"C. Liu , S. Wickström , H. Helgadottir , S. Egyhazi Brage","doi":"10.1016/j.iotech.2025.101135","DOIUrl":"10.1016/j.iotech.2025.101135","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"28 ","pages":"Article 101135"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145836609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
80P A phase I trial of optimized autologous tumor-infiltrating lymphocyte therapy without exogenous IL-2 in patients with advanced non-small cell lung cancer 无外源性IL-2的优化自体肿瘤浸润淋巴细胞治疗晚期非小细胞肺癌的I期临床试验
Immuno-oncology technology Pub Date : 2025-12-01 Epub Date: 2025-12-26 DOI: 10.1016/j.iotech.2025.101165
J. Li , X. Chen , J. Ma , Q. Xu , X. Guo , Y. Zhou , W. Li , W. Zhuang , H. Jin , J. Xu
{"title":"80P A phase I trial of optimized autologous tumor-infiltrating lymphocyte therapy without exogenous IL-2 in patients with advanced non-small cell lung cancer","authors":"J. Li , X. Chen , J. Ma , Q. Xu , X. Guo , Y. Zhou , W. Li , W. Zhuang , H. Jin , J. Xu","doi":"10.1016/j.iotech.2025.101165","DOIUrl":"10.1016/j.iotech.2025.101165","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"28 ","pages":"Article 101165"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145836732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
49P Baseline neutrophil-to-lymphocyte ratio as a predictive biomarker for immunotherapy in metastatic non-small cell lung cancer: A systematic review and meta-analysis 基线中性粒细胞与淋巴细胞比率作为转移性非小细胞肺癌免疫治疗的预测性生物标志物：一项系统综述和荟萃分析
Immuno-oncology technology Pub Date : 2025-12-01 Epub Date: 2025-12-26 DOI: 10.1016/j.iotech.2025.101132
N. Otkhozoria , E. Makharashvili , A. Toloraia , D. Kvaratskhelia , T. Melkadze
{"title":"49P Baseline neutrophil-to-lymphocyte ratio as a predictive biomarker for immunotherapy in metastatic non-small cell lung cancer: A systematic review and meta-analysis","authors":"N. Otkhozoria , E. Makharashvili , A. Toloraia , D. Kvaratskhelia , T. Melkadze","doi":"10.1016/j.iotech.2025.101132","DOIUrl":"10.1016/j.iotech.2025.101132","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"28 ","pages":"Article 101132"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145837265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书